CN107375896A - For suppressing the Chinese patent drug of cancer cell multiplication - Google Patents
For suppressing the Chinese patent drug of cancer cell multiplication Download PDFInfo
- Publication number
- CN107375896A CN107375896A CN201710496071.9A CN201710496071A CN107375896A CN 107375896 A CN107375896 A CN 107375896A CN 201710496071 A CN201710496071 A CN 201710496071A CN 107375896 A CN107375896 A CN 107375896A
- Authority
- CN
- China
- Prior art keywords
- parts
- cancer cell
- chinese patent
- patent drug
- cell multiplication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to a kind of health medicine, more particularly to a kind of Chinese patent drug for being used to suppress cancer cell multiplication, it is made up of the raw material of following parts by weight:15 20 parts of active peptides, 14 18 parts of ganoderma spove powder, 8 11 parts of Semen Coicis extract, 69 parts of arasaponin, 36 parts of raspberry, 36 parts of Poria cocos, 47 parts of matrimony vine, 23 parts of water caltrop, 35 parts of curcuma zedoary;This Chinese patent drug can mitigate tumor patient pain, suppress cancer cell multiplication, promoting blood circulation and removing blood stasis, dredging the channel, enhancing immune function of human body.
Description
Technical field
The present invention relates to a kind of health medicine, more particularly to a kind of Chinese patent drug for being used to suppress cancer cell multiplication.
Background technology
With the development of life, the quality of life of people improves, but people have but lacked physical exercise, so overall
The general level of the health reduces, immunity degradation, cancer cell diffusion, cancer cell multiplication, cytopathy, and malignant tumour occurs, various diseases
Appearance, it is in great pain, if treated and inhibit not in time, then symptom can be further serious, in order to suppress the diffusion of cancer cell
With propagation, present hospital can all take operation or be treated with Western medicine, and so not only speed is fast, and rapid-action, still
Side effect of the Western medicine often to human body is bigger, and many Western medicine simply take stopgap measures and do not control root, so being all of short duration to inhibit cancer
Cell, and pain cannot also be alleviated.
The content of the invention
It is an object of the invention to overcome the deficiencies in the prior art, avoids cancer cell multiplication, and relaxing tumor pain unbearably, and provides
A kind of Chinese patent drug for being used to suppress cancer cell multiplication, this Chinese patent drug can mitigate tumor patient pain, suppress cancer cell multiplication,
Promoting blood circulation and removing blood stasis, dredging the channel, enhancing immune function of human body.
The purpose of the present invention is achieved by the following measures:A kind of Chinese patent drug for being used to suppress cancer cell multiplication, by
The raw material composition of following parts by weight:Active peptides 15-20 parts, ganoderma spove powder 14-18 parts, Semen Coicis extract 8-11
Part, arasaponin 6-9 parts, raspberry 3-6 parts, Poria cocos 3-6 parts, matrimony vine 4-7 parts, water caltrop 2-3 parts, curcuma zedoary 3-5 parts.
Preferably, the parts by weight of described each raw material are as follows:Active peptides 17-19 parts, ganoderma spove powder 15-17
Part, Semen Coicis extract 9-10 parts, arasaponin 7-8 parts, raspberry 4-5 parts, Poria cocos 4-5 parts, matrimony vine 5-6 parts, water caltrop
2.2-2.7 part, curcuma zedoary 3.5-4.5 parts.
Preferably, the parts by weight of described each raw material are as follows:18 parts of active peptides, 16 parts of ganoderma spove powder, the heart of a lotus seed
9.5 parts of seed of jog's tears extract, 7.5 parts of arasaponin, 4.5 parts of raspberry, 4.5 parts of Poria cocos, 5.5 parts of matrimony vine, 2.5 parts of water caltrop, cowherb
4 parts of art.
It is a kind of a kind of material secreted by human body itself to active peptides, human growth hormone is called, by pituitary gland point
Secrete, be mainly distributed in nerve fiber and other histoorgans, take part in growing and protein, fat, sugar three for human body
The metabolism of big material, exactly because secretory volume increases or reduced in vivo for it, control the normal aggregate velocity of protein, matter
Amount, controls normal replication and the synthesis of cell.Active peptides in the present invention extract from cattle and sheep marrow.
Ganoderma spove powder, because its nutritional ingredient and active component are all very abundant, it is necessary to protect under cryogenic
Deposit, in order to avoid failure.Spore powder with crushed sporoderm has the activity of stronger external poisoning cancer cell.Ganoderma spove powder is applied to chemotherapy
Tumor patient, postoperative patients build up health, and improve symptom;Valetudinarian, the person of just recovering from a dangerous illness;To worry beyond measure, the mind, which is lost, supports,
Night sleeps bad, the health care recovery of muscle power and failure of memory;The chronic disease such as angiocardiopathy, diabetes, chronic hepatitis, disease of old people
The auxiliary conditioning of patient;The elderly's nourishes, anti-aging, beautifying face and moistering lotion.
Semen Coicis extract, tepor;It is sweet, it is light;Returns spleen, stomach, lung channel, there is the effect of whitening anti-aging,《Compendium of Materia Medica》
Call adlay " appearance, macrobiosis of making light of one's life by commiting suicide are stayed in invigorating spleen and reinforcing stomach, tonifying lung heat-clearing, expelling wind and eliminating dampness, beauty treatment ".Adlay is that cellulosic is most in five cereals
High, it contains abundant protein, grease, vitamin, mineral matter and carbohydrate, has whitening, except spot function, to lower part of the body oedema
People have curative effect especially.Adlay can promote the metabolism of internal blood and moisture, have the effect such as diuresis, consumer edema, and can help
Defecation is helped, can pre- anti-cancer.Semen Coicis extract is very helpful to post-operative recovery.
Arasaponin, bitter, micro-sweet, be pseudo-ginseng principle active component, hematopoietic growth can be promoted, research is also
It was found that the Rg1 and Rb1 in arasaponin are the effective monomers for promoting hematopoiesis, it can constantly promote people's bone marrow granulocyte, erythroid hematopoiesis
The propagation of progenitor cells, the effect to grain system progenitor cells are better than CFU-E.Promoting blood circulation, promote blood circulation active, have suppression blood small
Plate assembles and the effect of increase heart and brain CBF.For cardiovascular and cerebrovascular disease.
Raspberry, it is sweet, put down, the five poisonous creatures: scorpion, viper, centipede, house lizard, toad, there is the effect of anti-curing cancers, free radical is wreaked havoc such as ruffian in vivo, damage
Histocyte, change DNA molecular structure, so as to cause the generation of cancer.In raspberry containing it is a kind of be very useful to health
Composition-anthocyanin, it, which has, removes free radical, the function of anti-curing cancers generation.
Poria cocos, it is sweet, light, mild-natured, there is the effect of anticancer, increase the cytotoxic effect of macrophage.Methylol Fu
Siberian cocklebur polysaccharide can be remarkably reinforced mouse serum complement number and special antigen-binding cells number.The acid non-specific ester of increase
Enzyme positive lymphocyte number.Strengthen the cytotoxicity of T lymphocytes.
Matrimony vine, it is sweet, put down, immunity can be improved, improve the phagocytic function of phagocyte, improve the propagation energy of lymphocyte
Power.A kind of BRM of regulation immune response is not only, and nerve -- endocrine -- immunological regulation net can be passed through
Network plays antitumaous effect.
Water caltrop, sweet, cool, nontoxic, anticancer, denaturation and hyperblastosis of the real alcohol leaching aqueous of water chestnut to cancer cell have suppression
Effect, invigorating the spleen of invigorating the spleen and benefiting qi, strong stock knee, strong power QI invigorating.
Curcuma zedoary, pungent, bitter, temperature.Return liver, the spleen channel;Suppress platelet aggregation and antithrombus formation, it is antibacterial, anti-inflammatory, antitumor,
Promoting qi circulation and relieving pain, product dissipating bind, dissipating blood stasis with potent drugs effect can be controlled.
The beneficial effects of the invention are as follows:The Chinese patent drug that the present invention is produced by being reasonably formulated, can be with promoting blood circulation and removing blood stasis, thin
Degrading the channel, enhancing immune function of human body, suppress cancer cell multiplication, when coordinating zero malicious therapy curing cancers operation, using in sheet into
Medicine can reduce the toxic side effect of operation, mitigate tumor patient pain, improve life quality, and this Chinese patent drug is free of western medicine composition,
There is no any side effect.
Embodiment
In order to deepen the understanding of the present invention, below in conjunction with embodiment, the invention will be further described.
Embodiment 1:A kind of Chinese patent drug for being used to suppress cancer cell multiplication, is made up of the raw material of following weight:Active peptides
15 Kg, the Kg of ganoderma spove powder 14, the Kg of Semen Coicis extract 8, the Kg of arasaponin 6, the Kg of raspberry 3, Poria cocos 3
Kg, the Kg of matrimony vine 4, the Kg of water caltrop 2, the Kg of curcuma zedoary 3.
Embodiment 2:A kind of Chinese patent drug for being used to suppress cancer cell multiplication, is made up of the raw material of following weight:Active peptides
20 Kg, the Kg of ganoderma spove powder 18, the Kg of Semen Coicis extract 11, the Kg of arasaponin 9, the Kg of raspberry 6, Poria cocos 6
Kg, the Kg of matrimony vine 7, the Kg of water caltrop 3, the Kg of curcuma zedoary 5.
Embodiment 3:A kind of Chinese patent drug for being used to suppress cancer cell multiplication, is made up of the raw material of following weight:Active peptides
17 Kg, the Kg of ganoderma spove powder 15, the Kg of Semen Coicis extract 9, the Kg of arasaponin 7, the Kg of raspberry 4, Poria cocos 4
Kg, the Kg of matrimony vine 5, the Kg of water caltrop 2.2, the Kg of curcuma zedoary 3.5.
Embodiment 4:A kind of Chinese patent drug for being used to suppress cancer cell multiplication, is made up of the raw material of following weight:Active peptides
19 Kg, the Kg of ganoderma spove powder 17, the Kg of Semen Coicis extract 10, the Kg of arasaponin 8, the Kg of raspberry 5, Poria cocos 5
Kg, the Kg of matrimony vine 6, the Kg of water caltrop 2.7, the Kg of curcuma zedoary 4.5.
Embodiment 5:A kind of Chinese patent drug for being used to suppress cancer cell multiplication, is made up of the raw material of following weight:Active peptides
18 Kg, the Kg of ganoderma spove powder 16, the Kg of Semen Coicis extract 9.5, the Kg of arasaponin 7.5, raspberry 4.5 Kg, Fu
The Kg of Siberian cocklebur 4.5, the Kg of matrimony vine 5.5, the Kg of water caltrop 2.5, the Kg of curcuma zedoary 4.
Embodiment 6:A kind of Chinese patent drug for being used to suppress cancer cell multiplication, is made up of the raw material of following weight:Active peptides
16 Kg, ganoderma spove powder 17Kg, the Kg of Semen Coicis extract 9.5, the Kg of arasaponin 7, the Kg of raspberry 5, Poria cocos 4
Kg, the Kg of matrimony vine 5.5, the Kg of water caltrop 3, the Kg of curcuma zedoary 4.
Active peptides are the important couriers for linking up information between iuntercellular and organ in the present invention, pass through endocrine, nerveous system
The modes such as system exercise delicate transfering function, so that body combination is into a series of tight control system of height;Thoroughly control
Gene mutation, prevent normal cell from making a variation.Ganoderma spove powder, rich in the selenium of cancer-resisting substance in plant one, with active peptides knot
Close, cancerous tissue can be directly entered, correct the juvenile cell of variation, make source of the cancer cell without regeneration.Radix Notoginseng is promoting blood circulation and removing blood stasis, dispel
Stasis of blood life is new, promotes excretion of the body to cancer cell toxin, mitigates the pain caused by cancerous swelling;Ginseng, reinforce vital energy, improve people
Body combined anti-cancer ability, improves a poor appetite, enhances metabolism, and the T lymphocyte functions that patient can be made low return to normal water
It is flat.
The case of tumor patient is set forth below, to illustrate the effect of the present invention:
Zhao, people from Puyang oilfield of Henan, it was checked out before 2 years with malignant tumour, breaks up in II levels, gradual cancer cell diffusion is got over
Come more serious, then taken the Chinese patent drug in the present invention, just taken one week pain slight relief, taken one month, arrive in succession
Cancer cell is chemically examined again by hospital, and inspection result is constant for the quantity of cancer cell, does not spread, and Zhao takes exercise everyday, keeps
Good mood, the immunity of body also gradually strengthen.
Week certain, Henan people from Jiaozhuo is uncomfortable before one month, to certain hospital carry out laboratory examination, be diagnosed as tumour,
I level differentiateds, the mood of subsequent patient is depressed, thinks and oneself obtained incurable disease, and an accidental chance has used this hair
Chinese patent drug in bright, the state of an illness slightly take a turn for the better, and mood also maintains good state, then receive zero while this medicine of user
Malicious therapy, this medicine alleviate the pain of patient during treatment, and tumour slowly mitigates, and have spent a period of time again, week certain
The state of an illness recovery from illness.
Claims (3)
- A kind of 1. Chinese patent drug for being used to suppress cancer cell multiplication, it is characterised in that:It is made up of the raw material of following parts by weight:Activity Polypeptide 15-20 parts, ganoderma spove powder 14-18 parts, Semen Coicis extract 8-11 parts, arasaponin 6-9 parts, raspberry 3- 6 parts, Poria cocos 3-6 parts, matrimony vine 4-7 parts, water caltrop 2-3 parts, curcuma zedoary 3-5 parts.
- 2. the Chinese patent drug according to claim 1 for being used to suppress cancer cell multiplication, it is characterised in that:Described each raw material Parts by weight are as follows:Active peptides 17-19 parts, ganoderma spove powder 15-17 parts, Semen Coicis extract 9-10 parts, pseudo-ginseng are total Saponin(e 7-8 parts, raspberry 4-5 parts, Poria cocos 4-5 parts, matrimony vine 5-6 parts, water caltrop 2.2-2.7 parts, curcuma zedoary 3.5-4.5 parts.
- 3. the Chinese patent drug according to claim 1 for being used to suppress cancer cell multiplication, it is characterised in that:Described each raw material Parts by weight are as follows:18 parts of active peptides, 16 parts of ganoderma spove powder, 9.5 parts of Semen Coicis extract, arasaponin 7.5 Part, 4.5 parts of raspberry, 4.5 parts of Poria cocos, 5.5 parts of matrimony vine, 2.5 parts of water caltrop, 4 parts of curcuma zedoary.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710496071.9A CN107375896A (en) | 2017-06-26 | 2017-06-26 | For suppressing the Chinese patent drug of cancer cell multiplication |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710496071.9A CN107375896A (en) | 2017-06-26 | 2017-06-26 | For suppressing the Chinese patent drug of cancer cell multiplication |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107375896A true CN107375896A (en) | 2017-11-24 |
Family
ID=60332707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710496071.9A Pending CN107375896A (en) | 2017-06-26 | 2017-06-26 | For suppressing the Chinese patent drug of cancer cell multiplication |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107375896A (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1251765A (en) * | 1998-10-21 | 2000-05-03 | 肖厚杰 | Chinese medicine for treating cancers |
CN1355030A (en) * | 2000-11-25 | 2002-06-26 | 赵香花 | 'Tongyuhuazhi' pill |
CN1403147A (en) * | 2002-10-24 | 2003-03-19 | 河北以岭医药研究院有限公司 | Medicines composition for raising body's immunity and its prepn |
CN1403089A (en) * | 2002-09-29 | 2003-03-19 | 复旦大学 | Chinese medicine prepn containing arasaponin and its prepn process |
CN101474236A (en) * | 2008-01-01 | 2009-07-08 | 陈剑伟 | Ganoderma lucidum wall-broken spore powder capsule |
CN101496603A (en) * | 2009-02-19 | 2009-08-05 | 南方李锦记有限公司 | Health-care food with enhancing immunity and antioxidation functions |
CN104323240A (en) * | 2014-10-21 | 2015-02-04 | 胡安然 | Full-nutrition formula food for colorectal cancer |
CN104352887A (en) * | 2014-10-22 | 2015-02-18 | 安徽博格生物科技有限公司 | Anti-tumor comprehensive conditioning cream and preparing technology thereof |
-
2017
- 2017-06-26 CN CN201710496071.9A patent/CN107375896A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1251765A (en) * | 1998-10-21 | 2000-05-03 | 肖厚杰 | Chinese medicine for treating cancers |
CN1355030A (en) * | 2000-11-25 | 2002-06-26 | 赵香花 | 'Tongyuhuazhi' pill |
CN1403089A (en) * | 2002-09-29 | 2003-03-19 | 复旦大学 | Chinese medicine prepn containing arasaponin and its prepn process |
CN1403147A (en) * | 2002-10-24 | 2003-03-19 | 河北以岭医药研究院有限公司 | Medicines composition for raising body's immunity and its prepn |
CN101474236A (en) * | 2008-01-01 | 2009-07-08 | 陈剑伟 | Ganoderma lucidum wall-broken spore powder capsule |
CN101496603A (en) * | 2009-02-19 | 2009-08-05 | 南方李锦记有限公司 | Health-care food with enhancing immunity and antioxidation functions |
CN104323240A (en) * | 2014-10-21 | 2015-02-04 | 胡安然 | Full-nutrition formula food for colorectal cancer |
CN104352887A (en) * | 2014-10-22 | 2015-02-18 | 安徽博格生物科技有限公司 | Anti-tumor comprehensive conditioning cream and preparing technology thereof |
Non-Patent Citations (2)
Title |
---|
张军林等: "《简明生物化学》", 30 June 2014, 武汉:华中师范大学出版社 * |
王立晖等: "《生物活性多肽特性与营养学应用研究》", 30 November 2016, 天津:天津大学出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1762236B (en) | Health-caring product capable of increasing human immunity and its preparation method | |
CN102885301A (en) | Composition for enhancing immunity and preparation method thereof | |
CN102526478B (en) | Formula of health-care medicine with functions of strengthening immunity and reducing blood sugar | |
CN102526479B (en) | Health-care medicine formula with functions of enhancing immunity and lowering blood sugar | |
CN102349608A (en) | Healthcare product combination for clearing and nourishing throat and preparation method thereof | |
CN101884783B (en) | Wheat bran polypeptide-containing anti-fatigue traditional Chinese medicine and preparation method thereof | |
CN108066384A (en) | A kind of Chinese medicine preparation with strengthen immunity and preparation method thereof | |
CN108721407A (en) | Two empty constitution conditioning lavipeditum powder of a kind of gas sun and preparation method thereof | |
CN110693029A (en) | Mulberry leaf and bitter gourd functional food capable of reducing blood sugar | |
CN107375896A (en) | For suppressing the Chinese patent drug of cancer cell multiplication | |
CN103933146A (en) | Pollen product capable of adjusting human body immunity | |
CN102885313A (en) | Anti-fatigue health care product | |
CN113599457A (en) | A Chinese medicinal composition for treating diabetes, and its preparation method | |
CN106798786A (en) | Cordyceps militaris agate card compressing tablet and preparation method thereof | |
CN102078600A (en) | Anti-cancer compound ganoderma composition, application thereof and pharmaceutical composition containing same | |
CN101147585B (en) | Functional food suitable for woman with hyperplasia of mammary gland | |
CN112056553A (en) | Functional food with kidney-tonifying and yang-strengthening effects and preparation method thereof | |
CN1250273C (en) | Venom capsule for treating brain cancer | |
CN110404021A (en) | A kind of rhizoma polygonati preparation and preparation method | |
CN104523829A (en) | Propolis and danshen root health food | |
CN104305200A (en) | Peruvian ginseng and worm chrysalis health-care product and preparation method thereof | |
CN100441213C (en) | Subhealth treating Chinese medicine prepn and its prepn process | |
CN102613564B (en) | Ginseng, cartialgenous and lucid ganoderma capsule and preparation method of ginseng, cartialgenous and lucid ganoderma capsule | |
CN106723022A (en) | A kind of sika deer velvet antler peacilomyce hepiahi bacterium capsule and preparation method thereof | |
CN105054147A (en) | Health care soup and making method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171124 |